Minute Insight: Huma Buys AstraZeneca’s Amaze Digital Health Platform For Chronic Disease

The companies will continue to collaborate to expand the reach of AstraZeneca's Amaze platform for chronic disease while launching companion applications.

Minute Insight
• Source: Informa/Alamy

More from Minute Insights

More from Medtech Insight